News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
3 stories
Tagged Cardiovascular and metabolic from the headline and teaser, so some stories may be missed or misfiled.
- Trade pressBioPharma DiveNov 18, 2026‘Selling and marketing snake oil’: The debate over compounded GLP-1s
Proponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.
- Trade pressSTAT (pharma)Nov 17, 2026STAT+: Pharmalittle: We're reading about a Roche breast cancer pill, obesity drugs in children, and more
The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product
- Trade pressSTAT (pharma)Nov 16, 2026STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warns
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.